Barclays’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54
| Closed | – | – | 4680 |
|
|
2024
Q4 | $0 | Sell |
54
-248
| -82% | – | ﹤0.01% | 4598 |
|
|
2024
Q3 | $0 | Sell |
302
-36,097
| -99% | – | ﹤0.01% | 4552 |
|
|
2024
Q2 | $41K | Sell |
36,399
-39,430
| -52% | -$44.4K | ﹤0.01% | 3754 |
|
|
2024
Q1 | $685K | Sell |
75,829
-543
| -0.7% | -$4.91K | ﹤0.01% | 2650 |
|
|
2023
Q4 | $830K | Buy |
76,372
+67,360
| +747% | +$732K | ﹤0.01% | 2734 |
|
|
2023
Q3 | $73K | Sell |
9,012
-48,872
| -84% | -$396K | ﹤0.01% | 3440 |
|
|
2023
Q2 | $628K | Sell |
57,884
-585,131
| -91% | -$6.35M | ﹤0.01% | 2455 |
|
|
2023
Q1 | $4.44M | Buy |
643,015
+624,860
| +3,442% | +$4.31M | ﹤0.01% | 1149 |
|
|
2022
Q4 | $72K | Buy |
18,155
+15,937
| +719% | +$63.2K | ﹤0.01% | 3640 |
|
|
2022
Q3 | $15K | Buy |
+2,218
| New | +$15K | ﹤0.01% | 4048 |
|
|
2022
Q2 | – | Sell |
-5,996
| Closed | -$56K | – | 4984 |
|
|
2022
Q1 | $56K | Buy |
+5,996
| New | +$56K | ﹤0.01% | 3960 |
|
|
2020
Q3 | – | Sell |
-11,684
| Closed | -$118K | – | 3975 |
|
|
2020
Q2 | $118K | Buy |
11,684
+4,852
| +71% | +$49K | ﹤0.01% | 3049 |
|
|
2020
Q1 | $56K | Sell |
6,832
-6,035
| -47% | -$49.5K | ﹤0.01% | 3054 |
|
|
2019
Q4 | $111K | Sell |
12,867
-1,891
| -13% | -$16.3K | ﹤0.01% | 3419 |
|
|
2019
Q3 | $91K | Buy |
14,758
+6,670
| +82% | +$41.1K | ﹤0.01% | 3451 |
|
|
2019
Q2 | $134K | Buy |
8,088
+4,754
| +143% | +$78.8K | ﹤0.01% | 3431 |
|
|
2019
Q1 | $56K | Buy |
+3,334
| New | +$56K | ﹤0.01% | 3606 |
|
|
2018
Q4 | – | Sell |
-9,639
| Closed | -$385K | – | 4467 |
|
|
2018
Q3 | $385K | Sell |
9,639
-2,125
| -18% | -$84.9K | ﹤0.01% | 2762 |
|
|
2018
Q2 | $333K | Sell |
11,764
-3,361
| -22% | -$95.1K | ﹤0.01% | 2495 |
|
|
2018
Q1 | $232K | Buy |
+15,125
| New | +$232K | ﹤0.01% | 2761 |
|